<?xml version="1.0"?>
<rss version="2.0">
	<channel>
		<title>News for U.K.-based  companies .</title>
		<link>http://www.lifescience-online.com/</link>
		<description>News Feed Powered by Lifescience-online.com</description>
		<language>en-us</language>
		<pubDate>Wed, 08 Feb 2012 03:54:58 +0100</pubDate>
		<lastBuildDate>Wed, 08 Feb 2012 03:54:58 +0100</lastBuildDate>
		<category>News</category>		

		<image>
			<title>Lifescience-online</title>
			<url>http://rss.lifescience-online.com/images/logo.gif</url>
			<link>http://www.lifescience-online.com/</link>
			<width></width>
			<height></height>
			<description>Lifescience-online</description>
		</image>

		<item>
			<title>Impax Pharmaceuticals Licenses Exclusive U.S. Commercialization Rights to Zomig(R) (zolmitriptan) from AstraZeneca</title>
			<link>http://www.lifescience-online.com/Impax_Pharmaceuticals_Licenses_Exclusive_U_S__Comm,30766.html?portalPage=Lifescience+Today.News</link>
			<description><![CDATA[
<div valign='top' style='position:absolute;'><img align='right' src='http://static.lifescience-online.com/commonimages/news/4/0.gif' /></div><dl><dt><b>Category</b> :</dt><dd>Partnerships and Licensing</dd><br /><dt><b>Related companies</b> :</dt><dd><a href='http://www.lifescience-online.com/astrazeneca,339.html?portalPage=Business.Key+Players'><font color='#003366'><u color='#003366'>ASTRAZENECA PLC</u></font></a><br /><a href='http://www.lifescience-online.com/impax_pharmaceuticals,15095.html?portalPage=Business.Key+Players'><font color='#003366'><u color='#003366'>Impax Pharmaceuticals</u></font></a></dd><br /><dt><b>Related drugs</b> :</dt><dd><a href='http://www.lifescience-online.com/ZOLMITRIPTAN,3433.html?portalPage=Drugs'><font color='#003366'><u color='#003366'>ZOLMITRIPTAN</u></font></a></dd><br /><br /></dl>
]]></description>
			<pubDate>Tue, 31 Jan 2012 23:00:00 GMT</pubDate>
			<category>News</category>
		</item>

		<item>
			<title>Shire and Sangamo Collaborate to Develop Therapeutics for the Treatment of Hemophilia and Other Monogenic Diseases</title>
			<link>http://www.lifescience-online.com/Shire_and_Sangamo_Collaborate_to_Develop_Therapeut,30758.html?portalPage=Lifescience+Today.News</link>
			<description><![CDATA[
<div valign='top' style='position:absolute;'><img align='right' src='http://static.lifescience-online.com/commonimages/news/4/2.gif' /></div><dl><dt><b>Area</b> :</dt><dd>Hematology</dd><br /><dt><b>Category</b> :</dt><dd>Partnerships and Licensing</dd><br /><dt><b>Related companies</b> :</dt><dd><a href='http://www.lifescience-online.com/shire_pharmaceuticals_group,962.html?portalPage=Business.Key+Players'><font color='#003366'><u color='#003366'>SHIRE PHARMACEUTICALS GROUP PLC</u></font></a><br /><a href='http://www.lifescience-online.com/sangamo_biosciences,6629.html?portalPage=Business.Key+Players'><font color='#003366'><u color='#003366'>SANGAMO BIOSCIENCES INC</u></font></a></dd><br /><br /></dl>
]]></description>
			<pubDate>Tue, 31 Jan 2012 23:00:00 GMT</pubDate>
			<category>News</category>
		</item>

		<item>
			<title>BTG plc: Voraxaze(R) (glucarpidase) receives US regulatory approval</title>
			<link>http://www.lifescience-online.com/BTG_plc__Voraxaze___glucarpidase__receives_US_regu,30671.html?portalPage=Lifescience+Today.News</link>
			<description><![CDATA[
<div valign='top' style='position:absolute;'><img align='right' src='http://static.lifescience-online.com/commonimages/news/5/1.gif' /></div><dl><dt><b>Area</b> :</dt><dd>Other...</dd><br /><dt><b>Category</b> :</dt><dd>Scientific - Pipeline - Regulatory</dd><br /><dt><b>Related companies</b> :</dt><dd><a href='http://www.lifescience-online.com/btg,5278.html?portalPage=Business.Key+Players'><font color='#003366'><u color='#003366'>BTG PLC</u></font></a><br /><a href='http://www.lifescience-online.com/protherics,5587.html?portalPage=Business.Key+Players'><font color='#003366'><u color='#003366'>PROTHERICS PLC</u></font></a></dd><br /><dt><b>Related drugs</b> :</dt><dd><a href='http://www.lifescience-online.com/GLUCARPIDASE,1924.html?portalPage=Drugs'><font color='#003366'><u color='#003366'>GLUCARPIDASE</u></font></a></dd><br /><br /></dl>
]]></description>
			<pubDate>Tue, 17 Jan 2012 23:00:00 GMT</pubDate>
			<category>News</category>
		</item>

		<item>
			<title>Vernalis and Servier Sign Third Oncology Collaboration</title>
			<link>http://www.lifescience-online.com/Vernalis_and_Servier_Sign_Third_Oncology_Collabora,30561.html?portalPage=Lifescience+Today.News</link>
			<description><![CDATA[
<div valign='top' style='position:absolute;'><img align='right' src='http://static.lifescience-online.com/commonimages/news/4/2.gif' /></div><dl><dt><b>Category</b> :</dt><dd>Partnerships and Licensing</dd><br /><dt><b>Related companies</b> :</dt><dd><a href='http://www.lifescience-online.com/vernalis,384.html?portalPage=Business.Key+Players'><font color='#003366'><u color='#003366'>VERNALIS PLC</u></font></a><br /><a href='http://www.lifescience-online.com/servier,2113.html?portalPage=Business.Key+Players'><font color='#003366'><u color='#003366'>SERVIER</u></font></a></dd><br /><br /></dl>
]]></description>
			<pubDate>Tue, 17 Jan 2012 11:12:40 GMT</pubDate>
			<category>News</category>
		</item>

		<item>
			<title>Astex Announces Early Transfer of Epigenetics Project to GSK</title>
			<link>http://www.lifescience-online.com/Astex_Announces_Early_Transfer_of_Epigenetics_Proj,30647.html?portalPage=Lifescience+Today.News</link>
			<description><![CDATA[
<div valign='top' style='position:absolute;'><img align='right' src='http://static.lifescience-online.com/commonimages/news/4/0.gif' /></div><dl><dt><b>Area</b> :</dt><dd>Oncology</dd><br /><dt><b>Category</b> :</dt><dd>Partnerships and Licensing</dd><br /><dt><b>Related companies</b> :</dt><dd><a href='http://www.lifescience-online.com/glaxosmithkline,347.html?portalPage=Business.Key+Players'><font color='#003366'><u color='#003366'>GLAXOSMITHKLINE PLC</u></font></a><br /><a href='http://www.lifescience-online.com/astex_therapeutics,5086.html?portalPage=Business.Key+Players'><font color='#003366'><u color='#003366'>ASTEX THERAPEUTICS INC</u></font></a></dd><br /><br /></dl>
]]></description>
			<pubDate>Sun, 15 Jan 2012 23:00:00 GMT</pubDate>
			<category>News</category>
		</item>

		<item>
			<title>Otsuka Pharmaceutical and UCB focus collaboration in the area of Central Nervous System (CNS) disorders</title>
			<link>http://www.lifescience-online.com/Otsuka_Pharmaceutical_and_UCB_focus_collaboration_,30637.html?portalPage=Lifescience+Today.News</link>
			<description><![CDATA[
<div valign='top' style='position:absolute;'><img align='right' src='http://static.lifescience-online.com/commonimages/news/4/3.gif' /></div><dl><dt><b>Area</b> :</dt><dd>Immunomodulation</dd><br /><dt><b>Category</b> :</dt><dd>Partnerships and Licensing</dd><br /><dt><b>Related companies</b> :</dt><dd><a href='http://www.lifescience-online.com/celltech_group,5331.html?portalPage=Business.Key+Players'><font color='#003366'><u color='#003366'>CELLTECH GROUP PLC</u></font></a><br /><a href='http://www.lifescience-online.com/ucb_sa,5332.html?portalPage=Business.Key+Players'><font color='#003366'><u color='#003366'>UCB SA</u></font></a><br /><a href='http://www.lifescience-online.com/otsuka_pharmaceutical_co,7515.html?portalPage=Business.Key+Players'><font color='#003366'><u color='#003366'>OTSUKA PHARMACEUTICAL CO  LTD</u></font></a></dd><br /><dt><b>Related drugs</b> :</dt><dd><a href='http://www.lifescience-online.com/CERTOLIZUMAB_PEGOL,1866.html?portalPage=Drugs'><font color='#003366'><u color='#003366'>CERTOLIZUMAB PEGOL</u></font></a></dd><br /><br /></dl>
]]></description>
			<pubDate>Thu, 12 Jan 2012 23:00:00 GMT</pubDate>
			<category>News</category>
		</item>

		<item>
			<title>Prasco Laboratories Launches Authorized Generic of Shire plc (SHPGY)&#039;s Carbatrol(R)</title>
			<link>http://www.lifescience-online.com/Prasco_Laboratories_Launches_Authorized_Generic_of,30603.html?portalPage=Lifescience+Today.News</link>
			<description><![CDATA[
<div valign='top' style='position:absolute;'><img align='right' src='http://static.lifescience-online.com/commonimages/news/5/3.gif' /></div><dl><dt><b>Area</b> :</dt><dd>Central Nervous System</dd><br /><dt><b>Category</b> :</dt><dd>Scientific - Pipeline - Regulatory</dd><br /><dt><b>Related companies</b> :</dt><dd><a href='http://www.lifescience-online.com/shire_pharmaceuticals_group,962.html?portalPage=Business.Key+Players'><font color='#003366'><u color='#003366'>SHIRE PHARMACEUTICALS GROUP PLC</u></font></a><br /><a href='http://www.lifescience-online.com/prasco_laboratories,9986.html?portalPage=Business.Key+Players'><font color='#003366'><u color='#003366'>Prasco Laboratories LLC</u></font></a></dd><br /><dt><b>Related drugs</b> :</dt><dd><a href='http://www.lifescience-online.com/CARBAMAZEPINE,10188.html?portalPage=Drugs'><font color='#003366'><u color='#003366'>CARBAMAZEPINE</u></font></a></dd><br /><br /></dl>
]]></description>
			<pubDate>Wed, 11 Jan 2012 23:00:00 GMT</pubDate>
			<category>News</category>
		</item>

	</channel>
</rss>
